Hemostats Market, By Type (Oxidized Regenerated Cellulose, Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Combination Hemostats, Flowable Hemostats, and Topical Hemostats), By Application, By Formulation, By Deployment mode, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5104
|
Published Date
April 2026
|
Pages
387
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Hemostats Market size was valued at US$ 5,460.52 Million in 2025, expanding at a CAGR of 8.20% from 2026 to 2033.
Hemostats are medical devices and products used to control or stop bleeding during surgical procedures or after injuries. They work by promoting localized blood clot formation, helping reduce blood loss and improving patient safety in both planned surgeries and emergency care settings. Many hemostats are absorbable, meaning they are naturally broken down and absorbed by the body over time, and they are widely used across specialties such as orthopedics, cardiovascular surgery, neurosurgery, and general surgery.
The global hemostats market is witnessing steady growth, driven by the increasing number of surgical procedures worldwide and the rising need for effective bleeding control in clinical practice. According to data referenced by organizations such as the National Center for Biotechnology Information (NCBI), approximately 310 million major surgeries are performed globally each year, highlighting the sustained demand for hemostatic products in healthcare systems. In addition, clinical studies indicate that bleeding complications can occur in around 32% to 68% of surgical cases, further underscoring the importance of reliable hemostatic agents in improving surgical outcomes. With ongoing expansion of healthcare infrastructure and a strong focus on improving surgical safety and efficiency, the adoption of hemostats continues to increase across hospitals and surgical centers worldwide.
Hemostats Market- Market Dynamics
Strengthening Healthcare Systems through Infrastructure Expansion and Policy Initiatives
Global investment in healthcare infrastructure, along with proactive government policies, is reshaping the delivery of medical services and creating opportunities for scalable solutions such as field hospitals. Leading healthcare companies, including Fresenius Medical Care and Hillrom (now part of Baxter International), have reported increased use of modular hospital units and mobile care systems in response to national initiatives aimed at expanding hospital capacity and strengthening emergency preparedness.
Policy frameworks, such as the World Health Organization’s guidance on essential surgical care and various national health system strengthening programs, encourage the development of flexible and rapidly deployable healthcare facilities. These systems are designed to respond effectively to surges in patient demand, as well as crises such as natural disasters and pandemics. Together, this combination of infrastructure development and policy support is driving the wider adoption of field hospital solutions as cost-effective and scalable options for both planned healthcare expansion and emergency medical response.
Hemostats Market- Segmentation Analysis:
The Global Hemostats Market is segmented on the basis of Type, Application, Formulation, Deployment mode, End User, and Region.
The hemostats market is segmented into four formulation types: spray hemostats, gel/flowable, matrix hemostats, and sponge/sheet and powder forms. Among these, matrix hemostats, including flowable and fibrin-based variants, are expected to play a central role due to their strong clinical effectiveness and wide surgical applicability. These products combine a structural base such as gelatin or collagen with active agents like thrombin, enabling both a physical barrier effect and support for the body’s natural clotting process. This dual mechanism makes them suitable for a wide range of surgical situations. Matrix hemostats are particularly useful in controlling bleeding in irregular or hard-to-reach surgical sites, where traditional sponges or powders may be less effective. In addition, fibrin-based formulations closely mimic the body’s natural coagulation process and remain effective even under impaired clotting conditions, contributing to consistent surgical outcomes. Leading companies such as Baxter International Inc. and Johnson & Johnson continue to advance these technologies, highlighting their clinical importance. Overall, their versatility and reliable performance ensure their continued relevance in surgical practice.
The market is also segmented into eight application areas: orthopedic surgery, cardiovascular surgery, general surgery, neurosurgery, dental and oral surgery, gynecology and obstetrics, ENT and ophthalmology, and trauma and emergency care. Among these, orthopedic surgery is expected to witness significant growth due to the high volume of procedures and the critical need for effective bleeding management. Procedures such as joint replacements, fracture repairs, and spinal surgeries often involve bone and dense tissue, leading to substantial blood loss and making hemostatic agents a routine requirement. Clinical evidence shows that effective bleeding control in orthopedic procedures improves surgical visibility and supports better postoperative recovery. In addition, the rising number of orthopedic surgeries, particularly in developed healthcare systems, continues to drive steady demand for these products. Key companies such as Stryker Corporation and Medtronic remain actively engaged in developing advanced surgical solutions for this segment. Overall, the frequency of orthopedic procedures and the need for reliable hemostasis reinforce the sustained importance of this application area in the market.
Hemostats Market- Geographical Insights
The North American region, particularly the United States and Canada, is expected to witness significant growth in the hemostats market, driven by strong structural advantages and supportive healthcare policies. In the United States, healthcare spending exceeds $5 trillion as of 2024, accounting for roughly 18% of GDP. This substantial investment supports a highly developed surgical care ecosystem and ensures widespread access to advanced medical procedures.
The region’s advanced healthcare infrastructure, combined with a high volume of surgical interventions, creates consistent demand for effective bleeding control solutions such as hemostatic agents. Regulatory oversight by agencies like the U.S. Food and Drug Administration (FDA) ensures rigorous evaluation and approval of medical devices, enabling the safe introduction of innovative technologies while maintaining clinical reliability and trust. Furthermore, government-backed reimbursement systems such as Medicare and Medicaid, along with strong private insurance coverage and well-equipped hospital networks, encourage the adoption of advanced surgical products. Collectively, these factors reinforce North America’s leading position and expected growth trajectory in the global hemostats market.
Canada Hemostats Market- Country Insights
Canada’s hemostats market is shaped by its publicly funded and highly regulated healthcare system, where surgical procedures and medical devices are integral to patient care delivery. The country’s universal Medicare system, jointly funded by federal and provincial governments, is expected to support total healthcare expenditure of approximately CAD 399 billion in 2025. This sustained investment ensures consistent demand for surgical supplies, including hemostatic products, as hospitals continue to provide essential medical services across the population.
Health Canada regulates medical devices used for surgical bleeding control through a structured, risk-based approval framework. This regulatory oversight ensures the safety, quality, and effectiveness of hemostatic products, thereby strengthening clinical confidence and supporting improved patient outcomes. In addition, Canada has a well-established medical technology industry, with more than 1,500 companies concentrated primarily in Ontario and Québec. These firms contribute to innovation, research, and the supply of advanced medical solutions to hospitals nationwide. Overall, the combination of strong regulatory systems, consistent healthcare funding, and an active domestic medtech sector creates a supportive environment for the adoption and growth of advanced hemostatic solutions in Canada.
Hemostats Market- Competitive Landscape:
Due to the rising number of surgical procedures and the increasing need for effective blood management solutions, leading medical device companies such as Johnson & Johnson, Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, and Pfizer Inc. are continuously expanding and enhancing their hemostatic product portfolios. These organizations focus on developing solutions that are easy to use in operating rooms, reliable during complex surgical procedures, and adaptable across a wide range of clinical settings. Their products are distributed through hospitals, medical distributors, and global healthcare networks, with emphasis on product reliability, technological advancement, and strong clinical reputation.
As a result, healthcare providers have access to a broader range of effective tools for managing bleeding during surgical interventions. To further strengthen their market position and expand access to healthcare facilities, these companies continue to invest in innovation, strategic collaborations, and structured growth initiatives. For example, in June 2025, Johnson & Johnson MedTech launched the ETHICON™ 4000 Stapler, an advanced surgical device designed to support tissue sealing and reduce bleeding risks across various surgical procedures. This highlights how industry leaders are continuously refining their offerings to meet evolving surgical needs. In addition, other companies are increasing their focus on research and development, expanding distribution networks, and acquiring complementary technologies to deliver more comprehensive blood management solutions, ultimately contributing to safer and more efficient patient care.
Recent Developments:
- April 2025: Baxter International Inc. introduced a room-temperature stable version of its Hemopatch Sealing Hemostat, improving handling and accessibility in surgical environments. This development enhances product usability, supports wider clinical adoption, and strengthens Baxter’s position in the global hemostats market.
- April 2024: Baxter launched its Hemopatch Sealing Hemostat with room-temperature storage capability in Europe for use in hemostasis and tissue sealing. This strategic launch expands the company’s presence in international markets, improves product accessibility, and reinforces its growth in the global hemostats segment.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEMOSTATS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Medtronic
- Fresenius Medical Care
- Hillrom (Baxter International)
- GE Healthcare
- Philips Healthcare
- Stryker Corporation
- Drägerwerk AG & Co. KGaA
- Getinge AB
- Cardinal Health
- Johnson & Johnson (Ethicon)
- Becton Dickinson (BD)
- Siemens Healthineers
- Nihon Kohden Corporation
- 3M Healthcare
- Zimmer Biomet
- Integra LifeSciences
- C.R. Bard (Becton Dickinson)
- Shanghai United Imaging Healthcare
- Canon Medical Systems Corporation
- ConvaTec Group
- Others
GLOBAL HEMOSTATS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Oxidized Regenerated Cellulose
- Thrombin-Based Hemostats
- Gelatin-Based Hemostats
- Collagen-Based Hemostats
- Combination Hemostats
- Flowable Hemostats
- Topical Hemostats
GLOBAL HEMOSTATS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Orthopedic Surgery
- Cardiovascular Surgery
- General Surgery
- Neurosurgery
- Dental & Oral Surgery
- Gynecology & Obstetrics
- ENT & Ophthalmology
- Trauma & Emergency Care
GLOBAL HEMOSTATS MARKET, BY FORMULATION- MARKET ANALYSIS, 2020 - 2033
- Spray Hemostats
- Gel/Flowable
- Matrix Hemostats
- Sponge/Sheet
- Powder
GLOBAL HEMOSTATS MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2020 - 2033
- Intraoperative Use
- Postoperative Use
- Emergency / Trauma Use
- Minimally Invasive / Laparoscopic Surgeries
GLOBAL HEMOSTATS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Speciality Clinics
- Others
GLOBAL HEMOSTATS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Hemostats Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Hemostats Market Snippet by Type
2.1.2. Hemostats Market Snippet by Application
2.1.3. Hemostats Market Snippet by Formulation
2.1.4. Hemostats Market Snippet by Deployment mode
2.1.5. Hemostats Market Snippet by End User
2.1.6. Hemostats Market Snippet by Country
2.1.7. Hemostats Market Snippet by Region
2.2. Competitive Insights
3. Hemostats Key Market Trends
3.1. Hemostats Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hemostats Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hemostats Market Opportunities
3.4. Hemostats Market Future Trends
4. Hemostats Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hemostats Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Hemostats Market Landscape
6.1. Hemostats Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hemostats Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Oxidized Regenerated Cellulose
7.1.3. Thrombin-Based Hemostats
7.1.4. Gelatin-Based Hemostats
7.1.5. Collagen-Based Hemostats
7.1.6. Combination Hemostats
7.1.7. Flowable Hemostats
7.1.8. Topical Hemostats
8. Hemostats Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Orthopedic Surgery
8.1.3. Cardiovascular Surgery
8.1.4. General Surgery
8.1.5. Neurosurgery
8.1.6. Dental & Oral Surgery
8.1.7. Gynecology & Obstetrics
8.1.8. ENT & Ophthalmology
8.1.9. Trauma & Emergency Care
9. Hemostats Market – By Formulation
9.1. Overview
9.1.1. Segment Share Analysis, By Formulation, 2025 & 2033 (%)
9.1.2. Spray Hemostats
9.1.3. Gel/Flowable
9.1.4. Matrix Hemostats
9.1.5. Sponge/Sheet
9.1.6. Powder
10. Hemostats Market – By Deployment mode
10.1. Overview
10.1.1. Segment Share Analysis, By Deployment mode, 2025 & 2033 (%)
10.1.2. Intraoperative Use
10.1.3. Postoperative Use
10.1.4. Emergency / Trauma Use
10.1.5. Minimally Invasive / Laparoscopic Surgeries
11. Hemostats Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. Hospitals
11.1.3. Specialitity clinics
11.1.4. Others
12. Hemostats Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Hemostats Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Hemostats Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Hemostats Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Hemostats Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Hemostats Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Formulation, 2020 - 2033 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Deployment mode, 2020 - 2033 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Hemostats Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Medtronic
13.2.2. Fresenius Medical Care
13.2.3. Hillrom (Baxter International)
13.2.4. GE Healthcare
13.2.5. Philips Healthcare
13.2.6. Stryker Corporation
13.2.7. Drägerwerk AG & Co. KGaA
13.2.8. Getinge AB
13.2.9. Cardinal Health
13.2.10. Johnson & Johnson (Ethicon)
13.2.11. Becton Dickinson (BD)
13.2.12. Siemens Healthineers
13.2.13. Nihon Kohden Corporation
13.2.14. 3M Healthcare
13.2.15. Zimmer Biomet
13.2.16. Integra LifeSciences
13.2.17. C.R. Bard (Becton Dickinson)
13.2.18. Shanghai United Imaging Healthcare
13.2.19. Canon Medical Systems Corporation
13.2.20. ConvaTec Group
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEMOSTATS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Medtronic
- Fresenius Medical Care
- Hillrom (Baxter International)
- GE Healthcare
- Philips Healthcare
- Stryker Corporation
- Drägerwerk AG & Co. KGaA
- Getinge AB
- Cardinal Health
- Johnson & Johnson (Ethicon)
- Becton Dickinson (BD)
- Siemens Healthineers
- Nihon Kohden Corporation
- 3M Healthcare
- Zimmer Biomet
- Integra LifeSciences
- C.R. Bard (Becton Dickinson)
- Shanghai United Imaging Healthcare
- Canon Medical Systems Corporation
- ConvaTec Group
- Others
GLOBAL HEMOSTATS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Oxidized Regenerated Cellulose
- Thrombin-Based Hemostats
- Gelatin-Based Hemostats
- Collagen-Based Hemostats
- Combination Hemostats
- Flowable Hemostats
- Topical Hemostats
GLOBAL HEMOSTATS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Orthopedic Surgery
- Cardiovascular Surgery
- General Surgery
- Neurosurgery
- Dental & Oral Surgery
- Gynecology & Obstetrics
- ENT & Ophthalmology
- Trauma & Emergency Care
GLOBAL HEMOSTATS MARKET, BY FORMULATION- MARKET ANALYSIS, 2020 - 2033
- Spray Hemostats
- Gel/Flowable
- Matrix Hemostats
- Sponge/Sheet
- Powder
GLOBAL HEMOSTATS MARKET, BY DEPLOYMENT MODE- MARKET ANALYSIS, 2020 - 2033
- Intraoperative Use
- Postoperative Use
- Emergency / Trauma Use
- Minimally Invasive / Laparoscopic Surgeries
GLOBAL HEMOSTATS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Speciality Clinics
- Others
GLOBAL HEMOSTATS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
